Globus Medical Reports First Quarter 2026 Results
Globus Medical reported Q1 2026 revenue of $759.9 million, up 27% year-over-year, driven by 13.2% organic base business growth and the acquisition of Nevro. GAAP diluted EPS increased 66.6% to $0.90, while Non-GAAP EPS rose 64.7% to $1.12, fueled by margin expansion and operating leverage.
Key figures
- Eps
- 0.9
- Revenue
- $759.9 million
- Guidance
- FY26 revenue $3.18B-$3.22B (reaffirmed); Non-GAAP EPS $4.70-$4.80 (raised from $4.40-$4.50)
- Revenue Yoy
- 27.0%
- Non gaap eps
- 1.12
- Free cash flow
- $162.7 million
- Adjusted ebitda
- $245.3 million
- Gaap net income
- $124.3 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.